Brevan Howard Capital Management »

Krystal Biotech shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 14k 177.93

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf Call Option (EEM)
Financial Select Sector Spdr Financial (XLF)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 Call Option (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf (HYG)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
Spdr Trust Series 1 Tr Unit Put Option (SPY)
Ishares Ftse/xinhua China 25 China Lg-cap Etf (FXI)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
SEMICONDUCTOR HOLDRs TRUST Semiconductr Etf (SMH)
KraneShares CSI China Internet ETF Csi Chi Internet Call Option (KWEB)
Apple (AAPL)
Deutsche X-trackers Harvest Etf Xtrack Hrvst Csi Call Option (ASHR)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
Boeing Co option Call Option

View all positions for Brevan Howard Capital Management

Top funds holding Krystal Biotech

BlackRock
Vanguard Group
State Street Corporation
Redmile Group
Frazier Life Sciences Management
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Jennison Associates
Goldman Sachs Group
Lord, Abbett & Co
Nuveen Asset Management
Morgan Stanley
Woodline Partners
Invesco

View all funds holding Krystal Biotech